Corneal Graft Rejection 10 Years After Penetrating Keratoplasty in the Cornea Donor Study
Overview
Authors
Affiliations
Purpose: The aim of this study was to assess the effect of donor and recipient factors on corneal allograft rejection and evaluate whether a rejection event was associated with graft failure.
Methods: One thousand ninety subjects undergoing penetrating keratoplasty for a moderate risk condition (principally Fuchs dystrophy or pseudophakic corneal edema) were followed for up to 12 years. Associations of baseline recipient and donor factors with the occurrence of a rejection event were assessed in univariate and multivariate proportional hazards models.
Results: Among 651 eyes with a surviving graft at 5 years, the 10-year graft failure (±99% confidence interval) rates were 12% ± 4% among eyes with no rejection events in the first 5 years, 17% ± 12% in eyes with at least 1 probable, but no definite rejection event, and 22% ± 20% in eyes with at least 1 definite rejection event. The only baseline factor significantly associated with a higher risk of definite graft rejection was a preoperative history of glaucoma, particularly when previous glaucoma surgery had been performed and glaucoma medications were being used at the time of transplant (10-year incidence 35% ± 23% compared with 14% ± 4% in eyes with no history of glaucoma/intraocular pressure treatment, P = 0.008).
Conclusions: Patients who experienced a definite rejection event frequently developed graft failure raising important questions as to how we might change acute and long-term corneal graft management. Multivariate analysis indicated that previous use of glaucoma medications and glaucoma filtering surgery was a significant risk factor related to a definite rejection event.
Brotons-Munoz E, Ventura-Abreu N, Muniesa M, Milla E, Torras-Sanvicens J, Pazos M Saudi J Ophthalmol. 2025; 38(4):374-379.
PMID: 39943952 PMC: 11811404. DOI: 10.4103/sjopt.sjopt_166_24.
Biomedical Application of MSCs in Corneal Regeneration and Repair.
De Miguel M, Cadenas-Martin M, Stokking M, Martin-Gonzalez A Int J Mol Sci. 2025; 26(2).
PMID: 39859409 PMC: 11766311. DOI: 10.3390/ijms26020695.
Aldebasi T, Gangadharan S, Alshammari Y, Alruhaimi S, Alrashid S, Ardah H BMC Ophthalmol. 2024; 24(1):501.
PMID: 39548416 PMC: 11566242. DOI: 10.1186/s12886-024-03766-2.
Management and prevention of corneal graft rejection.
Mandal S, Maharana P, Kaweri L, Asif M, Nagpal R, Sharma N Indian J Ophthalmol. 2023; 71(9):3149-3159.
PMID: 37602601 PMC: 10565940. DOI: 10.4103/IJO.IJO_228_23.
Outcomes of Descemet's membrane keratoplasty in graft failure after penetrating keratoplasty.
Kasim B, Kocluk Y Int Ophthalmol. 2023; 43(9):3185-3191.
PMID: 37067695 DOI: 10.1007/s10792-023-02718-x.